Identification of shared biological features in four different lung cell lines infected with SARS-CoV-2 virus through

Xiaoxi Zhang1, Seungjun Ahn1,2, Peihua Qiu1

  • 1Department of Biostatistics, University of Florida, Gainesville, FL, United States.

Frontiers in Genetics
|September 4, 2023
PubMed

Insights

This study analyzed SARS-CoV-2 infection in lung cells, revealing common and unique responses. The "cytokine-cytokine receptor interaction" pathway is key for inflammation and immune response across all cell types.

Area of Science:

  • Molecular Biology
  • Virology
  • Genomics

Background:

  • The COVID-19 pandemic, caused by SARS-CoV-2, necessitates understanding viral infection mechanisms.
  • Identifying host responses is critical for developing effective antiviral therapies.

Purpose of the Study:

  • To investigate common and unique biological responses to SARS-CoV-2 infection across four lung cell lines.
  • To identify potential therapeutic targets by analyzing gene expression and pathway alterations.

Main Methods:

  • Differential expression (DE) analysis of RNA-seq data from NHBE, A549, A549.ACE2, and Calu3 cells.
  • Pathway analysis to identify significantly affected biological pathways.
  • Differential network (DN) analysis to assess network alterations in response to infection.

Main Results:

  • A549.ACE2 cells exhibited the highest number of differentially expressed genes, while NHBE cells showed the fewest.
  • Twelve overlapping differentially expressed genes were identified across all four cell lines.
  • The 'cytokine-cytokine receptor interaction' pathway was the only significant pathway common to all cell lines, indicating its role in inflammation and immune response.

Conclusions:

  • SARS-CoV-2 infection elicits varied responses across different lung cell types.
  • The 'cytokine-cytokine receptor interaction' pathway is a conserved response to SARS-CoV-2 infection.
  • Understanding these cellular and molecular responses can guide the development of targeted therapies for COVID-19.